Integra LifeSciences Holdings Corp. (IART)
13.98
+0.54
(+4.02%)
USD |
NASDAQ |
Oct 12, 16:00
13.98
0.00 (0.00%)
After-Hours: 20:00
Integra LifeSciences Holdings Free Cash Flow (Quarterly) : 10.50M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 10.50M |
| March 31, 2026 | -5.045M |
| December 31, 2025 | -19.60M |
| September 30, 2025 | 25.75M |
| June 30, 2025 | -11.23M |
| March 31, 2025 | -40.18M |
| December 31, 2024 | 11.19M |
| September 30, 2024 | -7.161M |
| June 30, 2024 | 10.69M |
| March 31, 2024 | 0.291M |
| December 31, 2023 | 34.22M |
| September 30, 2023 | 13.69M |
| June 30, 2023 | 12.73M |
| March 31, 2023 | 12.45M |
| December 31, 2022 | 70.88M |
| September 30, 2022 | 59.16M |
| June 30, 2022 | 57.07M |
| March 31, 2022 | 30.28M |
| December 31, 2021 | 41.79M |
| September 30, 2021 | 75.49M |
| June 30, 2021 | 84.66M |
| March 31, 2021 | 62.41M |
| December 31, 2020 | 51.84M |
| September 30, 2020 | 62.91M |
| June 30, 2020 | 25.90M |
| Date | Value |
|---|---|
| March 31, 2020 | -0.705M |
| December 31, 2019 | 66.99M |
| September 30, 2019 | -14.35M |
| June 30, 2019 | 30.86M |
| March 31, 2019 | 13.40M |
| December 31, 2018 | 11.97M |
| September 30, 2018 | 62.58M |
| June 30, 2018 | 16.21M |
| March 31, 2018 | 26.14M |
| December 31, 2017 | -2.148M |
| September 30, 2017 | 37.45M |
| June 30, 2017 | 16.05M |
| March 31, 2017 | 19.69M |
| December 31, 2016 | -14.66M |
| September 30, 2016 | 39.79M |
| June 30, 2016 | 54.84M |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 22.66M |
| September 30, 2015 | 21.05M |
| June 30, 2015 | 5.011M |
| March 31, 2015 | 22.72M |
| December 31, 2014 | 8.302M |
| September 30, 2014 | 22.30M |
| June 30, 2014 | 7.021M |
| March 31, 2014 | -0.081M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Penumbra, Inc. | 32.54M |
| Boston Scientific Corp. | 1.279B |
| Globus Medical, Inc. | 176.57M |
| Sight Sciences, Inc. | -5.682M |
| Abbott Laboratories | 1.991B |